gefurulimab   Click here for help

GtoPdb Ligand ID: 14698

Synonyms: ALXN-1720 | ALXN1720 | CON-9978 | Klygefa® | TPP-2511
Immunopharmacology Ligand
Compound class: Antibody
Comment: Gefurulimab (ALXN1720) is a bispecific VHH nanobody that binds complement component C5 (in the terminal complement cascade) and serum albumin [1]. It is designed to block enzymatic cleavage of C5 (into biologically active C5a and C5b fragments), and reduce inflammation. Binding to serum albumin extends the agent's systemic half-life and therapeutic window.
Bioactivity Comments
Gefurulimab (ALXN1720) binds human serum albumin with Kd 0.9 nM [1].
Selectivity at ligand targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
complement C5 Hs Antibody Binding 10.3 pKd - 1
⤷ pKd 10.3 (Kd 5.4x10-11 M) [1]
Description: Dissociation rate constant determined at pH7.4, determined by SPR on a Biacore instrument